Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2R)-2-{[(4-fluoro-3-methylphenyl)sulfonyl]amino}-N-hydroxy-2-tetrahydro-2H-pyran-4-ylacetamide
- Development stage
- Unknown
- Lead developer
- Astex Pharmaceuticals
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the benzenesulfonamide class, specifically a sulfonamide derivative with a hydroxamic acid moiety. It has not been approved for clinical use and is classified as an experimental drug. The molecule features a fluorinated aromatic ring and a tetrahydropyran substituent, which may confer unique binding properties or biological activity. There are no reported indications, clinical trials, or known mechanisms of action in humans. Its structure suggests potential utility as an enzyme inhibitor (such as metalloprotease or bacterial toxin inhibitors), but no specific pharmacological target has been confirmed[1][3][4].
- Other names
- (2R)-2-{[(4-fluoro-3-methylphenyl)sulfonyl]amino}-N-hydroxy-2-tetrahydro-2H-pyran-4-ylacetamide(2R)-2-(4-fluoro-3-methylbenzenesulfonamido)-N-hydroxy-2-(oxan-4-yl)acetamideLEF_BACANhydroxamate analogue 40
Beyond the preview
Go deeper on (2R)-2-{[(4-fluoro-3-methylphenyl)sulfonyl]amino}-N-hydroxy-2-tetrahydro-2H-pyran-4-ylacetamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (2R)-2-{[(4-fluoro-3-methylphenyl)sulfonyl]amino}-N-hydroxy-2-tetrahydro-2H-pyran-4-ylacetamide.